Clinical trials
Phase 2 Recurrence trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Celgene | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Eisai Inc. | 1 |
| Henrik Gregersen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 6 |
| Lymphoma | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Multiple Myeloma | 2 |
| Neoplasms | 2 |
| Blood Protein Disorders | 1 |
| Hematologic Diseases | 1 |
| Immunoproliferative Disorders | 1 |
| Leukemia | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.